Biocept Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Why Goldman Sachs expects Fed to skip October rate hike
- Brazilās Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Britain will not join Canada-led defence bank initiativeĀ
- Serbia's Vucic concedes defeat to student led movement in parliamentary election
- Stocks, bonds edge up ahead of 'formidable' week for risk
Biocept (BIOC) Reports Q2 Loss of $0.38/sh
August 12, 2020 4:19 PM EDTBiocept (NASDAQ: BIOC) reported Q2 EPS of ($0.38), versus ($0.05) reported last year. Revenue for the quarter came in at $1.2 million, versus $917.5 thousand reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More


